Spots Global Cancer Trial Database for Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
Official Title: Multi-Center Clinical Trial of Uterine Artery Embolization Treatment of Uterine Leiomyoma
Study ID: NCT00821275
Conditions
Interventions
Study Description
Brief Summary: The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Nanfang Hospital of Nanfang medical University, Guangzhou, Guangdong, China
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
the first Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Sun Yat-sen University, Guangzhou, Guangdong, China
Contact Details
Name: Hong Shan, M.D., PHD.
Affiliation: Third Affiliated Hospital, Sun Yat-Sen University
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
